OraSure Technologies, Inc. transforms health through actionable insight and decentralizes diagnostics to connect people to healthcare wherever they are. The Company improves the access, quality, and value of healthcare with innovation in effortless tests and sample management solutions. The Company, together with its wholly owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., is engaged in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. Its portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct consumers. Its products and services include OraQuick ADVANCE Rapid HIV1/2 Antibody Test, OraQuick HIV Self-Test, and Diagnostics Direct Syphilis Health Check.
公司代码OSUR
公司名称OraSure Technologies Inc
上市日期Nov 17, 1986
CEOEglinton Manner (Carrie)
员工数量501
证券类型Ordinary Share
年结日Nov 17
公司地址220 E First St
城市BETHLEHEM
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编18015
电话15036416115
网址https://www.orasure.com/
公司代码OSUR
上市日期Nov 17, 1986
CEOEglinton Manner (Carrie)